Lee, Iris <br/><br/>
Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism.  [electronic resource] 

 -  Journal of immunology (Baltimore, Md. : 1950)  Dec 2003 
 - 6929-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1767 
<br/><br/><label>Standard No.: </label>10.4049/jimmunol.171.12.6929  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Antigens, Surface--physiology<br/>Apoptosis Regulatory Proteins<br/>B7-1 Antigen<br/>B7-H1 Antigen<br/>Blood Proteins--antagonists & inhibitors<br/>Cell Differentiation--genetics<br/>Cell Division--genetics<br/>Chemokine CCL2--antagonists & inhibitors<br/>Clone Cells<br/>Dose-Response Relationship, Immunologic<br/>Female<br/>Graft Enhancement, Immunologic--methods<br/>Graft Rejection--immunology<br/>Graft Survival--drug effects<br/>Islets of Langerhans Transplantation--immunology<br/>Ligands<br/>Membrane Glycoproteins<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Organ Culture Techniques<br/>Peptides--antagonists & inhibitors<br/>Programmed Cell Death 1 Receptor<br/>Proteins--metabolism<br/>Receptors, CCR2<br/>Receptors, Chemokine--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Sirolimus--administration & dosage<br/>T-Lymphocyte Subsets--cytology<br/>Up-Regulation--drug effects